Loading...
On the Immunological Consequences of Conventionally Fractionated Radiotherapy.
Alfonso, Juan Carlos L Papaxenopoulou, Lito A Mascheroni, Pietro Hatzikirou, Haralampos
Alfonso, Juan Carlos L
Papaxenopoulou, Lito A
Mascheroni, Pietro
Hatzikirou, Haralampos
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-02-11
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 7.23 MB
Other Titles
Abstract
Emerging evidence demonstrates that radiotherapy induces immunogenic death on tumor cells that emit immunostimulating signals resulting in tumor-specific immune responses. However, the impact of tumor features and microenvironmental factors on the efficacy of radiation-induced immunity remains to be elucidated. Herein, we use a calibrated model of tumor-effector cell interactions to investigate the potential benefits and immunological consequences of radiotherapy. Simulations analysis suggests that radiotherapy success depends on the functional tumor vascularity extent and reveals that the pre-treatment tumor size is not a consistent determinant of treatment outcomes. The one-size-fits-all approach of conventionally fractionated radiotherapy is predicted to result in some overtreated patients. In addition, model simulations also suggest that an arbitrary increase in treatment duration does not necessarily result in better tumor control. This study highlights the potential benefits of tumor-immune ecosystem profiling during treatment planning to better harness the immunogenic potential of radiotherapy.
Citation
iScience. 2020 Feb 11;23(3):100897. doi: 10.1016/j.isci.2020.100897.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
2589-0042
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International